Company Filing History:
Years Active: 1997-2005
Title: Thomas Mulhern: Innovator in Asymmetric Synthesis
Introduction
Thomas Mulhern is a notable inventor based in Hudsonville, MI (US). He has made significant contributions to the field of chemistry, particularly in the area of asymmetric synthesis. With a total of 4 patents to his name, Mulhern's work has implications for the treatment of various medical conditions.
Latest Patents
One of Mulhern's latest patents focuses on the asymmetric synthesis of pregabalin. This invention provides a method for producing (S)-(+)-3-(aminomethyl)-5-methylhexanoic acid, commonly known as pregabalin, or its salts through an asymmetric hydrogenation synthesis. Pregabalin is recognized for its utility in treating seizure disorders, pain, and psychotic disorders. Additionally, the invention outlines intermediates that are useful in the production of pregabalin. Another patent details a method for making (S)-3-(aminomethyl)-5-methylhexanoic acid, which involves a series of chemical reactions starting with isovaleraldehyde and culminating in the hydrogenation of an alkali or alkaline earth metal carboxylate salt.
Career Highlights
Thomas Mulhern is currently associated with Warner-Lambert Company, where he continues to innovate and contribute to the field of pharmaceutical chemistry. His work has been instrumental in advancing methods that enhance the production of important therapeutic compounds.
Collaborations
Some of Mulhern's notable coworkers include Todd Michel Grote and Brian Keith Huckabee. Their collaborative efforts have likely contributed to the success of the projects they have undertaken together.
Conclusion
In summary, Thomas Mulhern is a distinguished inventor whose work in asymmetric synthesis has the potential to impact the treatment of various medical conditions. His contributions to the field are marked by a commitment to innovation and collaboration.